Child Health and the Pediatric Hematology-Oncology Workforce: 2020-2040
Heidi Russell1, Jeffrey Hord2, Colin J Orr3,4
1University of Texas Health Houston School of Public Health, Department of Management, Policy and Community Health, Houston, Texas.
Insights
The number of pediatric hematology-oncology (PHO) specialists is projected to grow 66% by 2040, but significant geographic disparities are expected. This highlights the need for strategic workforce planning to ensure equitable access to care for children with cancer and blood disorders.
Area of Science:
- Pediatric Subspecialty Workforce Analysis
- Healthcare Workforce Planning
- Pediatric Oncology and Hematology
Background:
- Pediatric hematology-oncology (PHO) is a well-established subspecialty caring for young patients with complex cancers and blood disorders.
- The current supply of clinically active PHO subspecialists in the U.S. is not well-defined, with some suggesting potential geographic oversaturation.
- Understanding future workforce needs is critical for ensuring adequate patient access to specialized pediatric care.
Purpose of the Study:
- To project the future supply of pediatric hematology-oncology subspecialists in the United States through 2040.
- To identify potential geographic maldistribution patterns within the PHO workforce.
- To inform strategies for optimizing the PHO subspecialty workforce for improved patient outcomes.
Main Methods:
- Utilized a microsimulation model to forecast the PHO workforce supply.
- Incorporated data from the American Board of Pediatrics and existing literature.
- Analyzed workforce projections under various scenarios, including changes in clinical time and fellowship sizes.
Main Results:
- The model predicts a 66% growth in the PHO subspecialist workforce by 2040 under baseline assumptions.
- Alternative scenarios indicated a potential growth variation of ±18% from the baseline.
- Significant geographic maldistribution is forecasted, with a projected 2.9-fold higher workforce equivalent per child in New England compared to the Mountain division by 2040.
Conclusions:
- The PHO subspecialty workforce is projected to grow substantially by 2040.
- Anticipated geographic maldistribution necessitates proactive interventions to ensure equitable care access.
- Educational, practice, policy, and research initiatives are recommended to address workforce challenges and enhance patient care.
Abstract:
Pediatric hematology-oncology (PHO) is 1 of the oldest recognized pediatric subspecialities. PHO physicians care for infants, children, adolescents, and young adults with all types of cancer and nonmalignant blood conditions, in many cases temporarily assuming the role of a primary care physician because of the complexity and intensity of treatment. However, the number of clinically active PHO subspecialists needed to care for children in the United States remains unknown. Recent papers suggest a potential oversaturation of PHO physicians in some geographic areas. This article is part of a Pediatrics supplement focused on projecting the future supply of the pediatric subspecialty workforce. It draws on information available in the literature, data from the American Board of Pediatrics, and findings from a new microsimulation model estimating the future supply of pediatric subspecialists through 2040. The model predicts a workforce growth in PHO subspecialists of 66% by 2040. Alternative scenarios, including changes in clinical time and fellowship size, resulted in a difference in growth of ±18% from baseline. The model also forecasts significant geographic maldistribution. For example, the current workforce is concentrated in the Northeast Census region and the model predicts the New England Census division will have a 2.9-fold higher clinical workforce equivalent per 100 000 children aged 0 to 18 years than the Mountain Census division by 2040. These findings suggest potential opportunities to improve the PHO subspecialty workforce and the outcomes and experiences of its patient population through educational changes, practice initiatives, policy interventions, and dedicated research.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
06:09Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine
Published on: January 12, 2024
Related Concept Videos
Hematopoiesis
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Regulation of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
